In order to test the tumor suppression effect of NaBu in different types of breast cancer, two kinds of breast cancer cell lines, the estrogen receptor negative MDA-MB-231 and the estrogen receptor positive MCF-7, were rendered the treatment of different concentration of NaBu (1–5 Mm, data not shown) for 2 days. The gene discussed is ESR1; the disease is breast carcinoma.